Qiagen NV | QIA - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 447K 138K 2026-03
argenx SE USD 417M 62M 2026-06
Avita Medical AUD 19.03M 1.95M 2025-12
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
IQVIA Holdings USD 574M 72M 2026-06
Moderna USD 216M 43M 2026-06
Organon & Co USD 424M 9M 2026-03
Qiagen NV USD 142.39M 11.49M 2026-03
Revvity USD 253.88M 2.15M 2026-03
Tectonic Therapeutic USD 6.43M 2.99M 2026-03
Viatris USD 928.8M 101.9M 2026-03
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03